BMRN

BioMarin Pharmaceutical
BMRN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$12.13B
EV
$11.63B
Shares Outstanding
191.75M
Beta
0.30

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$96.87
P/E 2025E
14.70x
P/Revenue 2025E
3.87x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About BioMarin Pharmaceutical Inc.

gainify
BMRN

BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mu...

Sector

Healthcare

Industry

Biotechnology

CEO

Hardy, Alexander

Employees

3,040

IPO Date

1999-07-26

Headquarters

770 Lindaro Street, San Rafael, California, 94901, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved